J. Byron

469 total citations
7 papers, 353 citations indexed

About

J. Byron is a scholar working on Pathology and Forensic Medicine, Pulmonary and Respiratory Medicine and Dermatology. According to data from OpenAlex, J. Byron has authored 7 papers receiving a total of 353 indexed citations (citations by other indexed papers that have themselves been cited), including 5 papers in Pathology and Forensic Medicine, 4 papers in Pulmonary and Respiratory Medicine and 1 paper in Dermatology. Recurrent topics in J. Byron's work include Systemic Sclerosis and Related Diseases (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Pulmonary Hypertension Research and Treatments (2 papers). J. Byron is often cited by papers focused on Systemic Sclerosis and Related Diseases (5 papers), Interstitial Lung Diseases and Idiopathic Pulmonary Fibrosis (4 papers) and Pulmonary Hypertension Research and Treatments (2 papers). J. Byron collaborates with scholars based in Australia, South Korea and United States. J. Byron's co-authors include Peter Nash, Wendy Stevens, Susanna Proudman, Janet Roddy, Mandana Nikpour, Joanne Sahhar, Pravin Hissaria, Peter Youssef, O. Moore and Jane Zochling and has published in prestigious journals such as Annals of the Rheumatic Diseases, Lara D. Veeken and Arthritis Research & Therapy.

In The Last Decade

J. Byron

7 papers receiving 352 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
J. Byron Australia 4 315 230 125 59 53 7 353
Vicent Fonollosa‐Pla Spain 11 366 1.2× 170 0.7× 161 1.3× 98 1.7× 85 1.6× 22 408
Lidia P Ananieva Hungary 3 259 0.8× 184 0.8× 96 0.8× 70 1.2× 56 1.1× 3 304
Hadi Poormoghim Iran 8 277 0.9× 124 0.5× 106 0.8× 103 1.7× 56 1.1× 17 320
Nicoletta Iannace Italy 7 199 0.6× 82 0.4× 40 0.3× 70 1.2× 56 1.1× 9 227
Nava Ferdowsi Australia 8 214 0.7× 96 0.4× 58 0.5× 76 1.3× 65 1.2× 23 234
Hannah Rouse Australia 7 204 0.6× 197 0.9× 89 0.7× 32 0.5× 15 0.3× 13 279
L. Mouthon France 4 207 0.7× 108 0.5× 33 0.3× 76 1.3× 84 1.6× 7 260
J. Sahhar Australia 4 159 0.5× 85 0.4× 55 0.4× 32 0.5× 33 0.6× 8 183
IH Tarner Germany 2 265 0.8× 60 0.3× 71 0.6× 121 2.1× 87 1.6× 4 290
D. Carmier France 9 146 0.5× 227 1.0× 89 0.7× 5 0.1× 21 0.4× 18 351

Countries citing papers authored by J. Byron

Since Specialization
Citations

This map shows the geographic impact of J. Byron's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by J. Byron with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites J. Byron more than expected).

Fields of papers citing papers by J. Byron

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by J. Byron. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by J. Byron. The network helps show where J. Byron may publish in the future.

Co-authorship network of co-authors of J. Byron

This figure shows the co-authorship network connecting the top 25 collaborators of J. Byron. A scholar is included among the top collaborators of J. Byron based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with J. Byron. J. Byron is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

7 of 7 papers shown
1.
Stevens, Wendy, Vivek Thakkar, O. Moore, et al.. (2012). LUNG DISEASE IS THE MAJOR CAUSE OF DEATH IN THE AUSTRALIAN SSc COHORT STUDY. Lara D. Veeken. 51. 2 indexed citations
2.
Thakkar, Vivek, Wendy Stevens, David L. Prior, et al.. (2012). N-terminal pro-brain natriuretic peptide in a novel screening algorithm for pulmonary arterial hypertension in systemic sclerosis: a case-control study. Arthritis Research & Therapy. 14(3). R143–R143. 91 indexed citations
3.
Moore, O., Nicole Goh, Tamera J. Corte, et al.. (2012). Extent of disease on high-resolution computed tomography lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Lara D. Veeken. 52(1). 155–160. 135 indexed citations
4.
Morrisroe, Kathleen, Wendy Stevens, J. Byron, et al.. (2012). FRI0261 Anti-phospholipid antibodies in systemic sclerosis: Prevalence and clinical correlations. Annals of the Rheumatic Diseases. 71. 402–402. 3 indexed citations
5.
Moore, O., Nicole Goh, Tamera J. Corte, et al.. (2012). FRI0243 Extent of disease on high-resolution CT lung is a predictor of decline and mortality in systemic sclerosis-related interstitial lung disease. Annals of the Rheumatic Diseases. 71. 396–396. 1 indexed citations
6.
Byron, J., Jane Zochling, Janet Roddy, et al.. (2011). MORTALITY AND CAUSES OF DEATH IN AN AUSTRALIAN SYSTEMIC SCLEROSIS COHORT. Internal Medicine Journal. 41. 12–12. 1 indexed citations
7.
Nikpour, Mandana, Pravin Hissaria, J. Byron, et al.. (2011). Prevalence, correlates and clinical usefulness of antibodies to RNA polymerase III in systemic sclerosis: a cross-sectional analysis of data from an Australian cohort. Arthritis Research & Therapy. 13(6). R211–R211. 120 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026